CALR mutations are infrequent in WHO-defined refractory anemia with ring sideroblasts.
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
M M
MM
Patnaik
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
A
A
Belachew
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
C
C
Finke
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
T L
TL
Lasho
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
C A
CA
Hanson
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
A
A
Tefferi
D000368:Aged; D000753:Anemia, Refractory / Q000175:diagnosis / Q000235:genetics*; D000756:Anemia, Sideroblastic / Q000175:diagnosis / Q000235:genetics*; D037282:Calreticulin / Q000235:genetics*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D014944:World Health Organization
C576483:CALR protein, human; D037282:Calreticulin